Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07082855
PHASE3

A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa

Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University

View on ClinicalTrials.gov

Summary

This is a multicenter, double-blind, randomized controlled clinical trial to get high - level evidence on minocycline's efficacy and safety(100mg/d, 200mg/d) for Retinitis pigmentosa and to find the optimal treatment dose.

Official title: A Multicenter, Double-Blind, Randomized Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

126

Start Date

2025-07-15

Completion Date

2028-06-30

Last Updated

2025-07-24

Healthy Volunteers

No

Interventions

DRUG

Minocycline 100mg

Capsules Minocycline 100mg po per day and placebo 100mg po per day for 12 months

DRUG

Minocycline 200mg

Capsules Minocycline 100mg po twice a day for 12 months

DRUG

Placebo

Capsules placebo 100mg po twice a day for 12 months

Locations (1)

Zhongshan Ophthalmic Center, Sun Yat-sen University

Guangzhou, Guangdong, China